Tags

Type your tag names separated by a space and hit enter

Long-term follow-up of patients with liver cirrhosis after endoscopic ethanol injection sclerotherapy for esophageal varices.
Hepatogastroenterology. 2003 Sep-Oct; 50(53):1556-9.H

Abstract

BACKGROUND/AIMS

Esophageal variceal hemorrhage is a severe complication of liver cirrhosis, and therapy for acute bleeding and prevention of hemorrhage are important. In this study, we evaluated the long-term cumulative survival rate of patients with esophageal varices after treatment with endoscopic ethanol injection sclerotherapy (EIS group) or pharmacological therapy (non-EIS group).

METHODOLOGY

All 110 patients were treated for their esophageal varices and their prognosis and complications were analyzed during the follow-up period.

RESULTS

The cumulative survival rate in the primary preventive EIS group was superior to that in the non-EIS group. The preventive EIS group had greater long-term survival rate than those treated on an emergency group. With respect to emergency therapy, the EIS group had better survival rates than the non-EIS group during the two-year follow-up period after esophageal variceal therapy.

CONCLUSIONS

We conclude that primary preventive EIS is an effective therapy for survival of patients with esophageal varices over a long-term period.

Authors+Show Affiliations

First Department of Internal Medicine, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

14571785

Citation

Okano, Hiroshi, et al. "Long-term Follow-up of Patients With Liver Cirrhosis After Endoscopic Ethanol Injection Sclerotherapy for Esophageal Varices." Hepato-gastroenterology, vol. 50, no. 53, 2003, pp. 1556-9.
Okano H, Shiraki K, Inoue H, et al. Long-term follow-up of patients with liver cirrhosis after endoscopic ethanol injection sclerotherapy for esophageal varices. Hepatogastroenterology. 2003;50(53):1556-9.
Okano, H., Shiraki, K., Inoue, H., Kawakita, T., Deguchi, M., Sugimoto, K., Sakai, T., Ohmori, S., Murata, K., & Nakano, T. (2003). Long-term follow-up of patients with liver cirrhosis after endoscopic ethanol injection sclerotherapy for esophageal varices. Hepato-gastroenterology, 50(53), 1556-9.
Okano H, et al. Long-term Follow-up of Patients With Liver Cirrhosis After Endoscopic Ethanol Injection Sclerotherapy for Esophageal Varices. Hepatogastroenterology. 2003 Sep-Oct;50(53):1556-9. PubMed PMID: 14571785.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term follow-up of patients with liver cirrhosis after endoscopic ethanol injection sclerotherapy for esophageal varices. AU - Okano,Hiroshi, AU - Shiraki,Katsuya, AU - Inoue,Hidekazu, AU - Kawakita,Tomoyuki, AU - Deguchi,Masatoshi, AU - Sugimoto,Kazushi, AU - Sakai,Takahisa, AU - Ohmori,Shigeru, AU - Murata,Kazumoto, AU - Nakano,Takeshi, PY - 2003/10/24/pubmed PY - 2004/2/26/medline PY - 2003/10/24/entrez SP - 1556 EP - 9 JF - Hepato-gastroenterology JO - Hepatogastroenterology VL - 50 IS - 53 N2 - BACKGROUND/AIMS: Esophageal variceal hemorrhage is a severe complication of liver cirrhosis, and therapy for acute bleeding and prevention of hemorrhage are important. In this study, we evaluated the long-term cumulative survival rate of patients with esophageal varices after treatment with endoscopic ethanol injection sclerotherapy (EIS group) or pharmacological therapy (non-EIS group). METHODOLOGY: All 110 patients were treated for their esophageal varices and their prognosis and complications were analyzed during the follow-up period. RESULTS: The cumulative survival rate in the primary preventive EIS group was superior to that in the non-EIS group. The preventive EIS group had greater long-term survival rate than those treated on an emergency group. With respect to emergency therapy, the EIS group had better survival rates than the non-EIS group during the two-year follow-up period after esophageal variceal therapy. CONCLUSIONS: We conclude that primary preventive EIS is an effective therapy for survival of patients with esophageal varices over a long-term period. SN - 0172-6390 UR - https://www.unboundmedicine.com/medline/citation/14571785/Long_term_follow_up_of_patients_with_liver_cirrhosis_after_endoscopic_ethanol_injection_sclerotherapy_for_esophageal_varices_ L2 - http://www.diseaseinfosearch.org/result/2658 DB - PRIME DP - Unbound Medicine ER -